CN105920093A - Medicinal composition for treating eczema - Google Patents
Medicinal composition for treating eczema Download PDFInfo
- Publication number
- CN105920093A CN105920093A CN201610471905.6A CN201610471905A CN105920093A CN 105920093 A CN105920093 A CN 105920093A CN 201610471905 A CN201610471905 A CN 201610471905A CN 105920093 A CN105920093 A CN 105920093A
- Authority
- CN
- China
- Prior art keywords
- eczema
- parts
- ginseng
- pharmaceutical composition
- volatile oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicinal composition for treating eczema, which is prepared from the following raw material medicines in parts by weight: 14 to 16 parts of panax notoginseng, 14 to 16 parts of ginkgo leaf, 3 to 5 parts of mint, 2 to 4 parts of evening primrose seed oil and 2 to 4 parts of eucalyptus oil. The invention overcomes the defects of an existing medicament for treating eczema and provides the medicinal composition with a good effect of treating eczema.
Description
Technical field
The present invention relates to technical field of traditional Chinese medicines, be specifically related to a kind of pharmaceutical composition treating eczema.
Background technology
Eczema, is a kind of scytitis reaction of the acute pruritus caused by multiple internal and external factor.Divide anxious
Property, three phases subacute, chronic.Acute stage tool oozes out tendency, and chronic phase then infiltrates, plump.Some
Patient directly translates into chronic eczema.Skin damages has polymorphy, symmetry, itch and easy recurrent exerbation
Etc. feature.The cause of disease, eczematosis, because of complexity, is often internal and external reasons interaction result.Internal cause is the chronicest to disappear
Change systemic disease, stress, insomnia, fatigue, emotional change, endocrinopathy, infection,
Dysbolisms etc., external cause such as living environment, climate change, food etc. all can affect sending out of eczema
Raw.Environmental stimuli such as daylight, cold, be dried, hot, hot water is scalded and various animal skin,
Plant, cosmetics, soap, staple fibre etc. all can induce.Be the complicated inside and outside factor cause one
Plant delayed allergy.Clinical manifestation, 1. damages performance by skin and is divided into acute, subacute, chronic three
Phase.(1) acute eczema skin damages is just the most intensive papule of grain grain size, papulo-vesicle or little water
Blister, substrate flush, gradually merge in flakes, owing to scratching, papule, papulo-vesicle or blister top are scratched
Ooze out in obvious point-like afterwards and little rotten to the corn face, blur margin.Such as scabies secondary infection, inflammation becomes apparent from,
Warts, purulence scab, folliculitis, furuncle etc. can be formed.Conscious violent itch.After being apt to occur in head, ear,
Distal limbs, scrotum, crissum etc., many symmetrical issues.(2) subacute eczema acute eczema inflammation
After alleviating, skin damages based on little papule, incrustation and the scales of skin that peel off, rarely seen a small amount of papulo-vesicle and erosion.Still have
Acutely itch.(3) chronic eczema does not often more transfer to slow because of acute, subacute eczema recurrent exerbation
Property eczema;Also can start to be chronic eczema.Show as illing skin to thicken, infiltrate, brownish red or
Pigmentation, rough surface, covers the scales of skin that peel off, or forms a scab because scratching.Conscious acute pruritus.It is common in
Shank, hand, foot, the fossa cubitalis, nest, vulva, anus etc..The course of disease is indefinite, easily recurs, prolonged
Do not heal.2. damage the scope involved according to skin, be divided into limitation eczema and the big class of universal eczema two.(1)
Limitation eczema occurs over just privileged site, i.e. can name with position, as wet in hand eczema, cysthus
Rash, eczema of scrotum, ear eczema, eczema mammae, perianal eczema, legs eczema etc..(2) general
Property eczema skin damage many, general or distribute in the multiple position of whole body.Such as coin eczema, autosensitization
Property eczema, weary lipid eczema.
Therefore, research will have important meaning for the Chinese medicine of eczema.
Summary of the invention
The technical problem to be solved in the present invention is the deficiency overcoming existing treatment eczema medicine, it is provided that a kind of
The treatment preferable pharmaceutical composition of eczema effect.
In pharmaceutical composition of the present invention, the consumption of each component is that inventor draws through a large amount of practice summaries
, it is made up of the bulk drug of following weight parts:
Pseudo-ginseng 14-16 part, ginkgo leaf 14-16 part, peppermint 3-5 part, evening primrose oil 2-4 part, eucalyptus
Oil 2-4 part.
Preferably, it is made up of the bulk drug of following weight parts:
15 parts of pseudo-ginseng, ginkgo leaf 15 parts, peppermint 4 parts, evening primrose oil 3 parts, volatile oil extracted from eucalyptus' leaves or twigs 3 parts.
The formulation of pharmaceutical composition of the present invention can be that washing lotion, liniment, paste etc. medically can connect
The formulation being subject to, their preparation method, supplementary product consumption are carried out by existing common process.
Pharmaceutical composition of the present invention is prepared the most in accordance with the following methods: peppermint is shredded, and uses steamed
The method that evaporates extracts volatile oil, and the sealing of volatile oil another device refrigerates, the dregs of a decoction are standby;The dregs of a decoction and pseudo-ginseng, ginkgo leaf
Adding 5-10 times of soak by water 2 times, each 1-2 hour, collecting decoction filters, dense, lets cool to phase
Between density 1.03-1.10, add evening primrose oil, volatile oil extracted from eucalyptus' leaves or twigs and the volatile oil of extraction, 5% oxybenzene second
Ester, stirs and filters after staticly settling 72 hours, and filtrate dispenses, packs, checks, i.e. obtains lotion.
Present invention additionally comprises aforementioned pharmaceutical compositions application in the medicine of preparation treatment eczema.
In pharmaceutical composition side of the present invention, share with pseudo-ginseng, ginkgo leaf, have clearing heat and detoxicating, antibacterial
Hemostasis, anticorrosion convergence myogenic effect, be the main ingredient for we;Evening primrose oil, stimulate circulation,
Activating aged cells, peppermint, volatile oil extracted from eucalyptus' leaves or twigs share, and have eliminating dampness antipruritic, the merit of expelling pus and promoting granulation, assist main ingredient
With disease of curing the disease, therefore it is we's adjuvants.
Pseudo-ginseng, is a jewel in Chinese medicine, remembers in Qing Dynasty's pharmaceutical texts supplementary Amplifications of the Compendium of Materia Medica
Carry: " ginseng qi-tonifying first, pseudo-ginseng enriches blood first, taste with and merit also etc., therefore claim Panax pseudoginseng, for
Most precious person in Chinese medicine." nature and flavor: taste is sweet;Micro-hardship;Warm in nature.Gui Jing: return Liver Channel;Stomach warp;
The heart channel of Hang-Shaoyin;Lung channel;Large intestine channel.Function: hemostasis;Dissipate blood;Analgesic therapy.Cure mainly: fall flutter the stasis of blood swell, the obstruction of qi in the chest
Angina, abdominal mass;Blood stasis is through closing;Dysmenorrhoea;Postpartum, stasis of blood the moon was suffered from abdominal pain;Sore, carbuncle and painful swelling.Usage and dosage: decoct
Soup, 3-9 gram;Grind into powder, 1-3 gram;Or enter ball, dissipate.External application: suitable reason, mill juice is coated with;Or grind into powder
Dress.Ecological environment: wild under the jungle of hillside, modern cultivates in the foot of the hill of height above sea level 800-1000m more
Tiltedly drape over one's shoulders, on mound gentle slope or under artificial cool canopy.Resource distribution: be distributed in Jiangxi, Hubei, Guangdong,
The ground such as Guangxi, Sichuan, Yunnan.Wild survivor is the most rare, mostly is cultivation.According to Pharmaceutical Analysis, pseudo-ginseng master
Contain six kinds of saponins and sitosterol, Daucosterol, flavone compound.Saponin is the main one-tenth of ginseng
Point, to strengthening muscle power, improving Myocardial Oxygen Metabolism, the tolerance improving Animal Anoxia has effect very much.For
Monarch drug in a prescription
Ginkgo leaf, for the dry leaf of Ginkgoaceae plant Ginkgo biloba Ginkgo biloba L..Autumn leaf still
Gather time green, be dried in time.Generally artificial cultivation.North, cultivation area is to Liaoning, and south reaches Guangdong,
From the east of Zhejiang, west reach Shaanxi, Gansu, southwest to Sichuan, Guizhou, the ground such as Yunnan.There is invigorating blood circulation
The stasis of blood, removes obstruction in channels to relieve pain, and astringes the lung and relievings asthma, and changes effect of turbid lipopenicillinase.For obstruction of collaterals by blood stasis, chest impediment and cardialgia,
Hemiplegia, the deficiency syndrome of the lung coughs and breathes heavily, hyperlipidemia.Medicinal part, the dry leaf of plant.Nature and flavor, sweet,
Bitter, puckery, flat.Gui Jing, the thoughts of returning home, lung channel.Effect, promoting blood circulation and removing blood stasis, remove obstruction in channels to relieve pain, astringe the lung and relieving asthma,
Change turbid lipopenicillinase.For ministerial drug
Peppermint, it is pungent cool property sweating antipyretic medicine, external application can control neuralgia, pruitus, fash and
Eczema etc..Main component volatile oil, peppermint contains menthol, have antisepsis and sterilization, anti-inflammatory, pain relieving,
The effect such as antipruritic.For adjutant.
Evening primrose oil, is the most excellent vegetable oil, and principle active component is unsaturated fat contained by it
Linoleic acid plus linolenic acid in acid, total content is about 85%.Evening primrose oil be excellent lubricant and
Natural moisture preserving agent.For adjutant.
Volatile oil extracted from eucalyptus' leaves or twigs, for myrtle blue gum Eucalyptus globulus Labill., Lauraceae
Plant camphor tree Cinnamomum camphora (L.) Sieb. or above-mentioned two section belongs to other plant warp together
The volatile oil that steam distillation obtains.Wind-expelling pain-stopping.For pruitus, neuralgia.For making medicine.
In sum, above all medicines share, and become heat-clearing and damp-drying drug altogether, detoxifying and relieving itching, the agent of expelling pus and promoting granulation,
Its mechanism of action is mainly with anti-inflammatory, pain relieving, convergence, anticorrosion, myogenic, clearing heat and detoxicating, antibacterial, only
Blood, timid rotten apocenosis etc..
Detailed description of the invention
With specific embodiment, the invention will be further described below, but the invention is not limited in these
Embodiment.
Embodiment 1
Pseudo-ginseng 140g, ginkgo leaf 160g, peppermint 110g, evening primrose oil 20g, volatile oil extracted from eucalyptus' leaves or twigs 160g.
Peppermint is shredded, and extracts volatile oil with vapor distillation method, and the sealing of volatile oil another device refrigerates, the dregs of a decoction are standby
With;The dregs of a decoction and pseudo-ginseng, ginkgo leaf add 5-10 times of soak by water 2 times, each 1-2 hour, merge and decoct
Liquid filters, dense to about 1000ml, lets cool between relative density 1.03-1.10, adds the moon
See grass oil, volatile oil extracted from eucalyptus' leaves or twigs and the volatile oil of extraction, the auxiliary material of addition conventional amount used, obtain liniment.
Embodiment 2
Pseudo-ginseng 160g, ginkgo leaf 140g, peppermint 130g, evening primrose oil 40g, volatile oil extracted from eucalyptus' leaves or twigs 140g.
Peppermint is shredded, and extracts volatile oil with vapor distillation method, and the sealing of volatile oil another device refrigerates, the dregs of a decoction are standby
With;The dregs of a decoction and pseudo-ginseng, ginkgo leaf add 5-10 times of soak by water 2 times, each 1-2 hour, merge and decoct
Liquid filters, dense to about 1000ml, lets cool between relative density 1.03-1.10, adds the moon
See grass oil, volatile oil extracted from eucalyptus' leaves or twigs and the volatile oil of extraction, the auxiliary material of addition conventional amount used, obtain paste.
Embodiment 3
Pseudo-ginseng 150g, ginkgo leaf 150g, peppermint 120g, evening primrose oil 30g, volatile oil extracted from eucalyptus' leaves or twigs 150g.
Peppermint is shredded, and extracts volatile oil with vapor distillation method, and the sealing of volatile oil another device refrigerates, the dregs of a decoction are standby
With;The dregs of a decoction and pseudo-ginseng, ginkgo leaf add 5-10 times of soak by water 2 times, each 1-2 hour, merge and decoct
Liquid filters, dense to about 1000ml, lets cool between relative density 1.03-1.10, adds the moon
Seeing grass oil, volatile oil extracted from eucalyptus' leaves or twigs and the volatile oil of extraction, 5% ethyl hydroxy benzoate 5-10ml, it is little that stirring staticly settles 72
Filtering time after, filtrate dispenses, packs, checks, i.e. obtains lotion.
Experimental example 4: the embodiment of the present invention 3 treats eczema clinical observation on the therapeutic effect:
Clinical data: observe patient 38 example altogether.
Observational technique
With this preparation clean and smear affected part, usage and dosage: take lotion 100ml add water 500ml dilution
Rear cleaning affected part, clean every time after with undiluted lotion smear affected part (or lotion to soak aseptic dry yarn wet
Apply), every day 2 times (the most each 1 time), within 10 days, it is a course for the treatment of, treats 2 courses for the treatment of.
Result
(1), efficacy assessment standard: judge result for the treatment of according to symptom and sign
Recovery from illness: skin damages and recovers normal, does not itches, or has slight gargalesthesia.
Effective: 70% skin damages and recovers normal, and remaining skin damages and gradually takes a turn for the better, with slight itch.
Taking a turn for the better: 30% skin damages and recovers normal, remaining skin damages has plumpness or few liquid to ooze out, with itch
Sense, but still can stand.
Invalid: locally skin damages less than improvement standard, or without improving, even deteriorate, symptom is without substantially becoming
Change.
(2), result for the treatment of:
Treating eczema 38 example altogether according to above standard, cure 18 examples, effective 12 examples, take a turn for the better 7 examples,
Invalid 1 example, total effective rate 97.4%.
Toxic and side effect
The lotion that embodiment 3 obtains during treating patient without significant discomfort.
Conclusion and discussion
By the observation of 38 example patients is treated, prompting: according to above data and clinical observation, this
The lotion of invention has notable result for the treatment of to eczema, has easy to use, price in clinical practice
The advantage such as cheap, toxic and side effect is little, applied widely, by clinical favorable comment.
As a comparison, present invention applicant is the most respectively to pseudo-ginseng, ginkgo leaf folk prescription, and pseudo-ginseng and silver
Contrast test has been done in the combination of apricot leaf, experimental result show the effect of prescription of the present invention considerably beyond more than
Contrast experiment's effect.
Claims (3)
1. the pharmaceutical composition treating eczema, it is characterised in that: this pharmaceutical composition be by under
The bulk drug stating weight portion is made:
Pseudo-ginseng 14-16 part, ginkgo leaf 14-16 part, peppermint 3-5 part, evening primrose oil 2-4 part, eucalyptus
Oil 2-4 part.
The pharmaceutical composition for the treatment of eczema the most according to claim 1, it is characterised in that: should
Pharmaceutical composition is made up of the bulk drug of following weight parts:
15 parts of pseudo-ginseng, ginkgo leaf 15 parts, peppermint 4 parts, evening primrose oil 3 parts, volatile oil extracted from eucalyptus' leaves or twigs 3 parts.
3. the pharmaceutical composition according to any one of claim 1-2 is at the medicine of preparation treatment eczema
In application.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610471905.6A CN105920093A (en) | 2016-06-24 | 2016-06-24 | Medicinal composition for treating eczema |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610471905.6A CN105920093A (en) | 2016-06-24 | 2016-06-24 | Medicinal composition for treating eczema |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105920093A true CN105920093A (en) | 2016-09-07 |
Family
ID=56829195
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610471905.6A Pending CN105920093A (en) | 2016-06-24 | 2016-06-24 | Medicinal composition for treating eczema |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105920093A (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1269212A (en) * | 2000-03-20 | 2000-10-11 | 兰金初 | Preparation of external-use Chinese medicine for chapped skin and chapped eczema |
CN104524125A (en) * | 2014-12-31 | 2015-04-22 | 冯凤 | Traditional Chinese medicine emulsifiable plaster for treating eczema and preparing method thereof |
CN105079214A (en) * | 2015-09-24 | 2015-11-25 | 皖南医学院 | Emulsion containing traditional Chinese medicine extracting solution and used for treating eczema and preparation method thereof |
CN105213557A (en) * | 2015-09-30 | 2016-01-06 | 罗奕珺 | A kind of Chinese medicine composition for the treatment of eczema |
CN105687960A (en) * | 2016-03-21 | 2016-06-22 | 廖辉 | Traditional Chinese medicine preparation for preventing infant eczema |
-
2016
- 2016-06-24 CN CN201610471905.6A patent/CN105920093A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1269212A (en) * | 2000-03-20 | 2000-10-11 | 兰金初 | Preparation of external-use Chinese medicine for chapped skin and chapped eczema |
CN104524125A (en) * | 2014-12-31 | 2015-04-22 | 冯凤 | Traditional Chinese medicine emulsifiable plaster for treating eczema and preparing method thereof |
CN105079214A (en) * | 2015-09-24 | 2015-11-25 | 皖南医学院 | Emulsion containing traditional Chinese medicine extracting solution and used for treating eczema and preparation method thereof |
CN105213557A (en) * | 2015-09-30 | 2016-01-06 | 罗奕珺 | A kind of Chinese medicine composition for the treatment of eczema |
CN105687960A (en) * | 2016-03-21 | 2016-06-22 | 廖辉 | Traditional Chinese medicine preparation for preventing infant eczema |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6027728A (en) | Herbal skin regeneration composition and method | |
CN104258304A (en) | Medicated wine for meridian unblocking, wind dispelling, collaterals activating and pain relieving | |
CN102008576B (en) | External traditional Chinese medicine for treating sprain and preparation method thereof | |
CN100387291C (en) | Medicine for treating pulmonary tuberculosis | |
CN111840416A (en) | Marrow-washing bone-setting liquid | |
CN105232987A (en) | Traditional Chinese medicine promoting neurosurgery postoperative rehabilitation | |
CN104548049A (en) | Traditional Chinese medicine composition for treating senile osteoporosis and preparation method thereof | |
CN102961633B (en) | A kind of preparation for being used to treat postpartum rheumatism | |
CN101780193A (en) | Special-effect plaster for treating fractures and various non-healing wounds | |
CN105250525A (en) | Traditional Chinese medicine lotion for treating diabetic foot and preparation method thereof | |
CN102178813B (en) | Slimming beauty scraping oil and preparation method thereof | |
CN105687543A (en) | External Chinese herba preparation for treating tumors | |
CN105920093A (en) | Medicinal composition for treating eczema | |
CN104971286A (en) | Traditional Chinese medicine composition for treating shoulder, waist and leg discomfort | |
CN104873723B (en) | A kind of burn-scald medicine containing cinnamon oil | |
CN111803564A (en) | Collateral-dredging liquid for dredging collaterals and relaxing tendons | |
CN103070994B (en) | Plaster for treating cervical and lumbar spondylosis | |
Chen | Herbology in Three Traditional Medicines for Acne | |
CN105832934A (en) | Traditional Chinese medicine for treating hypertension | |
CN105560582A (en) | Swelling eliminating and itch relieving ointment for treating chilblain and preparation method thereof | |
CN105232886A (en) | Sanlong Deida wine and preparation method | |
CN104689183A (en) | Medicinal liquor with swelling eliminating and blood stasis dispersing functions and preparing method thereof | |
CN104740019A (en) | Essential oil for treating recurrent oral ulcer | |
CN105106786A (en) | Traditional Chinese medicine composition capable of dredging collaterals and relaxing muscles as well as preparation and production method of composition | |
CN105963365A (en) | Pharmaceutical composition for treating bedsore |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160907 |
|
WD01 | Invention patent application deemed withdrawn after publication |